EBV-ASSOCIATED MYOPERICARDITIS

Course overview

CARDIOVASCULAR COMPLICATIONS STEMMING FROM EPSTEIN-BARR VIRUS (EBV) INFECTION, THOUGH RELATIVELY RARE, CARRY SIGNIFICANT IMPLICATIONS, ESPECIALLY IN IMMUNOCOMPROMISED INDIVIDUALS. THESE ISSUES ARISE FROM A COMBINATION OF DIRECT VIRAL TOXICITY AND THE IMMUNE SYSTEM'S RESPONSE, LEADING TO PATHOLOGICAL CHANGES SUCH AS MYOCARDIAL NECROSIS AND CARDIAC DILATATION. THE COMPLICATIONS INCLUDE CORONARY ARTERY DILATATION, CORONARY ARTERY ANEURYSMS, MYOPERICARDITIS, ACUTE MYOCARDIAL INFARCTION, VALVULAR HEART CONDITIONS, HEART FAILURE, PULMONARY ARTERIAL HYPERTENSION, AND MORE.LEFT UNADDRESSED, THE COMPLICATIONS LEAD TO SIGNIFICANT MORBIDITY AND MORTALITY, UNDERSCORING THE IMPORTANCE OF TIMELY AND APPROPRIATE MANAGEMENT. THE APPROPRIATE TREATMENT IN A MULTIDISCIPLINARY CARE SETTING IS NECESSARY TO OPTIMIZE THE CARE OF PATIENTS WITH EBV-RELATED MYOPERICARDITIS. THIS ACTIVITY REVIEWS THE EVALUATION AND TREATMENT OF EBV-ASSOCIATED MYOPERICARDITIS AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN EVALUATING AND TREATING PATIENTS WITH THIS CONDITION.